Literature DB >> 23351797

Is Option B+ the best choice?

Anna Coutsoudis1, Ameena Goga, Chris Desmond, Peter Barron, Vivian Black, Hoosen Coovadia.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23351797     DOI： 10.1016/S0140-6736(12)61807-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

1.  Preventing Mother To Child Transmission of HIV - Current strategies.

Authors:  Sushil Kumar
Journal:  Med J Armed Forces India       Date:  2014-10

2.  Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa.

Authors:  Landon Myer; Tamsin Phillips; Victoria Manuelli; James McIntyre; Linda-Gail Bekker; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-26       Impact factor: 3.731

3.  Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.

Authors:  Lyson Tenthani; Andreas D Haas; Olivia Keiser; Hannock Tweya; Andreas Jahn; Joep J van Oosterhout; Frank Chimbwandira; Zengani Chirwa; Wingston Ng'ambi; Alan Bakali; Sam Phiri; Landon Myer; Fabio Valeri; Marcel Zwahlen; Gilles Wandeler
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

4.  Global response to HIV: treatment as prevention, or treatment for treatment?

Authors:  Kim C E Sigaloff; Joep M A Lange; Julio Montaner
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

5.  National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.

Authors:  Beth A Tippett Barr; Monique van Lettow; Joep J van Oosterhout; Megan Landes; Ray W Shiraishi; Ermias Amene; Erik Schouten; Nellie Wadonda-Kabondo; Sundeep Gupta; Andrew F Auld; Thokozani Kalua; Andreas Jahn
Journal:  Lancet HIV       Date:  2018-11-19       Impact factor: 12.767

6.  Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana.

Authors:  Rebecca Zash; Sajini Souda; Jennifer Y Chen; Kelebogile Binda; Scott Dryden-Peterson; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

7.  Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa.

Authors:  Brandon A Knettel; Cody Cichowitz; James Samwel Ngocho; Elizabeth T Knippler; Lilian N Chumba; Blandina T Mmbaga; Melissa H Watt
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

8.  Universal combination antiretroviral regimens to prevent mother-to-child transmission of HIV in rural Zambia: a two-round cross-sectional study.

Authors:  Benjamin H Chi; Patrick Musonda; Mwila K Lembalemba; Namwinga T Chintu; Matthew G Gartland; Saziso N Mulenga; Maximillian Bweupe; Eleanor Turnbull; Elizabeth M Stringer; Jeffrey S A Stringer
Journal:  Bull World Health Organ       Date:  2014-06-05       Impact factor: 9.408

Review 9.  Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health.

Authors:  Christopher J Colvin
Journal:  Glob Public Health       Date:  2014-02-05

Review 10.  Prevention of mother-to-child transmission in South Africa: an ever-changing landscape.

Authors:  Rosie Burton; Janet Giddy; Kathryn Stinson
Journal:  Obstet Med       Date:  2015-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.